Photodynamic therapy in treatment of cutaneous and choroidal melanoma

Photodiagnosis and Photodynamic Therapy

Volumn 10, Issue 4, 2013, Pages 503-509

  Kawczyk Krupka, Aleksandra ^a   Bugaj, Andrzej M ^a,b   Latos, Wojciech ^a   Zaremba, Katarzyna ^a   Sieroń, Aleksander ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Faculty of Cosmetology and Educational Sciences   (Poland)

Author keywords

Cancer therapy; Melanoma; Photodynamic therapy; Skin cancer

Indexed keywords

5,10 DI (4 ACETAMIDOPHENYL) 15,20 DI (4 N METHYLPYRIDYL) PORPHYRIN; AMINOLEVULINIC ACID; BEVACIZUMAB; LUTETIUM TEXAPHYRIN; MESOTETRA 4 N METHYLPYRIDYLPORPHYRIN IODIDE; METHYLENE BLUE; PHEOPHORBIDE; PHOTOFRIN; PHOTOSENSITIZING AGENT; PHTHALOCYANINE ALUMINUM; PHTHALOCYANINE ZINC; TETRASULFOPHTHALOCYANINE ALUMINUM; UNCLASSIFIED DRUG; VERTEPORFIN;

ADVANCED CANCER; AMELANOTIC MELANOMA; ANTINEOPLASTIC ACTIVITY; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CELL VIABILITY; CHOROID MELANOMA; CUTANEOUS MELANOMA; CYTOTOXICITY; HUMAN; KERATOACANTHOMA; MELANOMA; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA; WHITE LIGHT;

CANCER THERAPY; MELANOMA; PHOTODYNAMIC THERAPY; SKIN CANCER;

ANIMALS; CHOROID NEOPLASMS; EVIDENCE-BASED MEDICINE; HUMANS; MELANOMA; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN NEOPLASMS;

EID: 84888023572     PISSN: 15721000     EISSN: 18731597     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2013.05.006     Document Type: Review

References (73)

1. Juzeniene A., Baturaite Z., Moan J. Sun exposure and melanomas on sun-shielded and sun-exposed body areas. Sunlight, vitamin D and skin cancer 2013, 1-15. Landes Bioscience and Springer Science+Business Media, Austin (Texas, USA). second ed. J. Reichrath (Ed.).
2. Chang A.E., Karnell L.H., Menck H.R. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. Cancer 1998, 83:1664-1678. The American College of Surgeons Commission on Cancer and the American Cancer Society.
3. Dummer R., Hauschild A., Guggenheim M., Keilholz U., Pentheroudakis G Cutaneous melanoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Annals of Oncology 2012, 23(Suppl. 7):vii86-vii91. on behalf of the ESMO Guidelines Working Group.
4. MacKie R.M., Bray C., Vestey J., Doherty V., Evans A., Thomson D., et al. Melanoma incidence and mortality in Scotland 1979-2003. British Journal of Cancer 2007, 96:1772-1777.
5. Micu E., Baturaite Z., Juzeniene A., Bruland Ø.S., Moan J.E. Superficial-spreading and nodular melanomas in Norway: a comparison by body site distribution and latitude gradients. Melanoma Research 2012, 22:460-465.
6. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M., et al. GLOBOCAN 2008 v2.0, cancer incidence and mortality worldwide: IARC cancer base no. 10 [Internet] 2012, International Agency for Research on Cancer, Lyon, France, Available from: http://globocan.iarc.fr [accessed 16.10.12], http://globocan.iarc.fr [accessed 16.10.12].
7. Zbytek B., Carlson J.A., Granese J., Ross J., Mihm M.C., Slominski A. Current concepts of metastasis in melanoma. Expert Review of Dermatology 2008, 3:569-585.
8. Jilaveanu L.B., Aziz S.A., Kluger H.M. Chemotherapy and biologic therapies for melanoma: do they work?. Clinics in Dermatology 2009, 27:614-625.
9. Huang Y.-Y., Vecchio D., Avci P., Yin R., Garcia-Diaz M., Hamblin M.R. Melanoma resistance to photodynamic therapy: new insights. Biological Chemistry 2013, 394:239-250.
10. Yamamura H., Ugawa S., Ueda T., Morita A., Shimada S. TRPM8 activation suppresses cellular viability in human melanoma. American Journal of Physiology. Cell Physiology 2008, 295:C296-C301.
11. Chudnovsky Y., Khavari P.A., Adams A.E. Melanoma genetics and the development of rational therapeutics. Journal of Clinical Investigation 2005, 115:813-824.
12. Slominski A., Tobin D.J., Shibahara S., Wortsman J. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiological Reviews 2004, 84:1155-1228.
13. Slominski A., Wortsman J., Carlson A.J., Matsuoka L.Y., Balch C.M., Mihm M.C. Malignant melanoma. Archives of Pathology & Laboratory Medicine 2001, 125:1295-1306.
14. Carlson J.A., Ross J.S., Slominski A., Linette G., Mysliborski J., Hill J., et al. Molecular diagnostics in melanoma. Journal of the American Academy of Dermatology 2005, 52:743-775. quiz 775-8.
15. Thompson J.F., Scolyer R.A., Kefford R.F. Cutaneous melanoma. Lancet 2005, 365:687-701.
16. Chapman P.B., Hauschild A., Robert C., Haanen J.B., Ascierto P., Larkin J., et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. New England Journal of Medicine 2011, 30(364):2507-2516.
17. De Agostinis P., Berg K., Cengel K.A., Foster T.H., Girotti A.W., Gollnick S.O., et al. Photodynamic therapy of cancer: an update. CA: A Cancer Journal for Clinicians 2011, 61:250-281.
18. Babilas P., Schreml S., Landthaler M., Szeimies R.M. Photodynamic therapy in dermatology: state-of-the-art. Photodermatology, Photoimmunology & Photomedicine 2010, 26:118-132.
19. Braathen L.R., Morton C.A., Basset-Seguin N., Bissonnette R., Gerritsen M.J., Gilaberte Y., et al. Photodynamic therapy for skin field cancerization: an international consensus, international society for photodynamic therapy in dermatology. Journal of the European Academy of Dermatology and Venereology 2012, 26:1036-1063.
20. Dougherty T.J., Gomer C.J., Henderson B.W., Jori G., Kessel D., Korbelik M., et al. Photodynamic therapy. Journal of the National Cancer Institute 1998, 90:889-905.
21. Allison R.R., Moghissi K. Photodynamic therapy (PDT): PDT mechanisms. Clinical Endoscopy 2013, 46:24-29.
22. Castano A.P., Mroz P., Hamblin M.R. Photodynamic therapy and anti-tumour immunity. Nature Reviews. Cancer 2006, 6:535-545.
23. Kwitniewski M., Juzeniene A., Głośnicka R., Moan J. Immunotherapy: a way to improve the therapeutic outcome of photodynamic therapy?. Photochemical & Photobiological Sciences 2008, 7:1011-1017.
24. Cohen C., Zavala-Pompa A., Sequeira J.H., Shoji M., Sexton D.G., Cotsonis G., et al. Mitogen-activated protein kinase activation is an early event in melanoma progression. Clinical Cancer Research 2002, 8:3728-3733.
25. Tong Z., Singh G., Rainbow A.J. Sustained activation of the extracellular signal regulated kinase pathway protects cells from photofrin-mediated photodynamic therapy. Cancer Research 2002, 62:5528-5535.
26. Ryter S.W., Gomer C.J. Nuclear factor kappa B binding activity in mouse L1210 cells following photofrin II-mediated photosensitization. Photochemistry and Photobiology 1993, 58:753-756.
27. Gewirtz D.A. Autophagy, senescence and tumor dormancy in cancer therapy. Autophagy 2009, 5:1232-1234.
28. Korbelik M., Dougherty G.J. Photodynamic therapy-mediated immune response against subcutaneous mouse tumors. Cancer Research 1999, 59:1941-1946.
29. Vonarx V., Foultier M.T., Anasagasti L., Morlet L., Lajat Y., Patrice T. Photodynamic effect on the specific antitumor immune activity. International Journal of Immunopharmacology 1997, 19:101-110.
30. Canti G., Lattuada D., Nicolin A., Taroni P., Valentini G., Cubeddu R. Antitumor immunity induced by photodynamic therapy with aluminium disulfonated phtalocyanines and laser light. Anticancer Drugs 1994, 5:443-447.
31. Vancikova Z. Principles of the photodynamic therapy and its impact on the immune system. Sbornik Lekarsky 1998, 99:1-11.
32. Kawczyk-Krupka A., Czuba Z., Szliszka E., Król W., Sieroń A. The role of photosensitized macrophages in photodynamic therapy. Oncology Reports 2011, 26:275-280.
33. Da{ogonek}browski J.M., Urbańska K., Arnaut L.G., Pereira M.M., Abreu A.R., Simões S., et al. Biodistribution and photodynamic efficacy of a watersoluble, stable, halogenated bacteriochlorin against melanoma. ChemMedChem 2011, 6:465-475.
34. Davids L.M., Kleemann B. Combating melanoma: the use of photodynamic therapy as a novel, adjuvant therapeutic tool. Cancer Treatment Reviews 2011, 37:37465-37475.
35. Haddad R., Blumenfeld A., Siegal A., Kaplan O., Cohen M., Skornick Y., et al. In vitro and in vivo effects of photodynamic therapy on murine malignant melanoma. Annals of Surgical Oncology 1998, 5:241-247.
36. Haddad R., Kaplan O., Greenberg R., Siegal A., Skornick Y., Kashtan H. Photodynamic therapy of murine colon cancer and melanoma using systemic aminolevulinic acid as a photosensitizer. International Journal of Surgical Investigation 2000, 2:171-178.
37. Szurko A., Krämer-Marek G., Wideł M., Ratuszna A., Habdas J., Kuś P. Photodynamic effects of two water soluble porphyrins evaluated on human malignant melanoma cells in vitro. Acta Biochimica Polonica 2003, 50:1165-1174.
38. Barge J., Decréau R., Julliard M., Hubaud J.C., Sabatier A.S., Grob J.J., et al. Killing efficacy of a new silicon phthalocyanine in human melanoma cells treated with photodynamic therapy by early activation of mitochondrion-mediated apoptosis. Experimental Dermatology 2004, 13:33-44.
39. Saczko J., Kulbacka J., Chwiłkowska A., Drag-Zalesińiska M., Wysocka T., Lugowski M., et al. The influence of photodynamic therapy on apoptosis in human melanoma cell line. Folia Histochemica et Cytobiologica 2005, 43:129-132.
40. Robertson C.A., Abrahamse H., Evans D. The in vitro PDT efficacy of a novel metallophthalocyanine (MPc) derivative and established 5-ALA photosensitizing dyes against human metastatic melanoma cells. Lasers in Surgery and Medicine 2010, 42:766-776.
41. Grimm S., Mvondo D., Grune T., Breusing N. The outcome of 5-ALA-mediated photodynamic treatment in melanoma cells is influenced by vitamin C and heme oxygenase-1. Biofactors 2011, 37:17-24.
42. Maduray K., Karsten A., Odhav B., Nyokong T. In vitro toxicity testing of zinc tetrasulfophthalocyanines in fibroblast and keratinocyte cells for the treatment of melanoma cancer by photodynamic therapy. Journal of Photochemistry and Photobiology B 2011, 103:98-104.
43. Maduray K., Odhav B., Nyokong T. In vitro photodynamic effect of aluminum tetrasulfophthalocyanines on melanoma skin cancer and healthy normal skin cells. Photodiagnosis and Photodynamic Therapy 2012, 9:32-39.
44. Da{ogonek}browski J.M., Urbanska K., Arnaut L.G., Pereira M.M., Abreu A.R., Simões S., et al. Biodistribution and photodynamic efficacy of a water-soluble, stable, halogenated bacteriochlorin against melanoma. ChemMedChem 2011, 6:465-475.
45. Sharma K.V., Bowers N., Davids L.M. Photodynamic therapy-induced killing is enhanced in depigmented metastatic melanoma cells. Cell Biology International 2011, 35:939-944.
46. Kim M.R., Morrison H., Mohammed S.I. Effect of a photoactivated rhodium complex in melanoma. Anticancer Drugs 2011, 22:896-904.
47. Choromańska A., Saczko J., Kulbacka J., Skolucka N., Majkowski M. The potential role of photodynamic therapy in the treatment of malignant melanoma - an in vitro study. Advances in Clinical and Experimental Medicine 2012, 21:179-185.
48. Radzi R., Osaki T., Tsuka T., Imagawa T., Minami S., Okamoto Y. Morphological study in B16F10 murine melanoma cells after photodynamic hyperthermal therapy with indocyanine green (ICG). Journal of Veterinary Medical Science 2012, 74:465-472.
49. Bolfarini G.C., Siqueira-Moura M.P., Demets G.J., Morais P.C., Tedesco A.C. In vitro evaluation of combined hyperthermia and photodynamic effects using magnetoliposomes loaded with cucurbituril zinc phthalocyanine complex on melanoma. Journal of Photochemistry and Photobiology B 2012, 115:1-4.
50. Sparsa A., Bellaton S., Naves T., Jauberteau M.O., Bonnetblanc J.M., Sol V., et al. Photodynamic treatment induces cell death by apoptosis or autophagy depending on the melanin content in two B16 melanoma cell lines. Oncology Reports 2013, 29:1196-1200.
51. Nelson J.S., McCullough J.L., Berns M.W. Photodynamic therapy of human malignant melanoma xenografts in athymic nude mice. Journal of the National Cancer Institute 1988, 80:56-60.
52. Panagopoulos J.A., Svitra P.P., Puliafito C.A., Gragoudas E.S. Photodynamic therapy for experimental intraocular melanoma using chloroaluminum sulfonated phthalocyanine. Archives of Ophthalmology 1989, 107:886-890.
53. Ozler S.A., Nelson J.S., Liggett P.E., de Queiroz J.M., Berns M.W. Photodynamic therapy of experimental subchoroidal melanoma using chloroaluminum sulfonated phthalocyanine. Archives of Ophthalmology 1992, 110:555-561.
54. Dellian M., Richert C., Gamarra F., Goetz A.E. Photodynamic eradication of amelanotic melanoma of the hamster with fast acting photosensitizers. International Journal of Cancer 1996, 65:246-248.
55. Young L.H., Howard M.A., Hu L.K., Kim R.Y., Gragoudas E.S. Photodynamic therapy of pigmented choroidal melanomas using a liposomal preparation of benzoporphyrin derivative. Archives of Ophthalmology 1996, 114:186-192.
56. Abels C., Fritsch C., Bolsen K., Szeimies R.M., Ruzicka T., Goerz G., et al. Photodynamic therapy with 5-aminolaevulinic acid induced porphyrins of an amelanotic melanoma in vivo. Journal of Photochemistry and Photobiology B 1997, 40:76-83.
57. Woodburn K.W., Fan Q., Kessel D., Luo Y., Young S.W. Photodynamic therapy of B16F10 murine melanoma with lutetium texaphyrin. Journal of Investigative Dermatology 1998, 110:746-751.
58. Hu L., Wu X., Song Y., Young L.H., Gragoudas E.S. Photodynamic therapy of pigmented choroidal melanomas in rabbits. Zhonghua Yan Ke Za Zhi 2002, 38:491-494. [article in Chinese; abstract in English].
59. Otake E., Sakuma S., Torii K., Maeda A., Ohi H., Yano S., et al. Effect and mechanism of a new photodynamic therapy with glycoconjugated fullerene. Photochemistry and Photobiology 2010, 86:1356-1363.
60. Tammela T., Saaristo A., Holopainen T., Ylä-Herttuala S., Andersson L.C., Virolainen S., et al. Photodynamic ablation of lymphatic vessels and intralymphatic cancer cells prevents metastasis. Science Translational Medicine 2011, 3(69):ra11.
61. Da{ogonek}browski J.M., Krzykawska M., Arnaut L.G., Pereira M.M., Monteiro C.J., Simões S., et al. Tissue uptake study and photodynamic therapy of melanoma-bearing mice with a nontoxic, effective chlorin. ChemMedChem 2011, 6:1715-1726.
62. Rapozzi V., Zorzet S., Zacchigna M., Drioli S., Xodo L.E. The PDT activity of free and pegylated pheophorbide a against an amelanotic melanoma transplanted in C57/BL6 mice. Investigational New Drugs 2013, 31:192-199.
63. Wagner M., Suarez E.R., Theodoro T.R., Machado Filho C.D., Gama M.F., Tardivo J.P., et al. Methylene blue photodynamic therapy in malignant melanoma decreases expression of proliferating cell nuclear antigen and heparanases. Clinical and Experimental Dermatology 2012, 37:527-533.
64. Idris N.M., Gnanasammandhan M.K., Zhang J., Ho P.C., Mahendran R., Zhang Y. In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers. Nature Medicine 2012, 18:1580-1585.
65. Barbazetto I.A., Lee T.C., Rollins I.S., Chang S., Abramson D.H. Treatment of choroidal melanoma using photodynamic therapy. American Journal of Ophthalmology 2003, 135:898-899.
66. Donaldson M.J., Lim L., Harper C.A., Mackenzie J., G Campbell W. Primary treatment of choroidal amelanotic melanoma with photodynamic therapy. Clinical & Experimental Ophthalmology 2005, 33:548-549.
67. Soucek P., Cihelkova I. Photodynamic therapy with verteporfin in subfoveal amelanotic choroidal melanoma. Neuroendocrinology Letters 2006, 27:145-148.
68. Tuncer S., Kir N., Shields C.L. Dramatic regression of amelanotic choroidal melanoma with PDT following poor response to brachytherapy. Ophthalmic Surgery, Lasers & Imaging 2012, 43:38-40.
69. Campbell W.G., Pejnovic T.M. Treatment of amelanotic choroidal melanoma with photodynamic therapy. Retina 2012, 32:1356-1362.
70. Sheleg S.V., Zhavrid E.A., Khodina T.V., Kochubeev G.A., Istomin Y.P., Chalov V.N., et al. Photodynamic therapy with chlorin e(6) for skin metastases of melanoma. Photodermatology, Photoimmunology & Photomedicine 2004, 20:21-26.
71. Alloo A., Garibyan L., LeBoeuf N., Lin G., Werchniak A., Hodi F.S., et al. Photodynamic therapy for multiple eruptive keratoacanthomas associated with vemurafenib treatment for metastatic melanoma. Archives of Dermatology 2012, 148:363-366.
72. Canal-Fontcuberta I., Salomão D.R., Robertson D., Cantrill H.L., Koozekanani D., Rath P.P., et al. Clinical and histopathologic findings after photodynamic therapy of choroidal melanoma. Retina 2012, 32:942-948.
73. Baldea I., Filip A.G. Photodynamic therapy in melanoma - an update. Journal of Physiology and Pharmacology 2012, 63:109-118.